Ludwig Cancer Research is a global community of leading scientists pursuing innovative ways to prevent and control cancer. From basic research to clinical trials, in individual laboratories or as part of international teams, our researchers are tackling the hardest questions, spotting the connections and the possibilities. At Ludwig, we test our work against the one measure that matters — improving human health. Ludwig Cancer Research is a global community of leading scientists pursuing innovative ways to prevent and control cancer. From basic research to clinical trials, in individual laboratories or as part of international teams, our researchers are tackling the hardest questions, spotting the connections and the possibilities. At Ludwig, we test our work against the one measure that matters — improving human health.

  I am a physician-scientist with special interest in tumor immunology. I was initially trained as a physician specializing in internal medicine with a focus on clinical hematology. After my clinical training I was interested in laboratory research, and I joined Thierry Boon's group at the Ludwig Institute for Cancer Research in Brussels. I first studied tumor antigens and associated immune responses in hematological malignancies. I later joined the clinical research team, which was developing phase 1 and 2 clinical vaccine trials in melanoma and other types of cancer. The biggest part of my career has been devoted to setting up and running clinical immunotherapy trials. I also have developed a laboratory research project aimed at characterizing the immune and inflammatory reactions that take place in human melanoma metastases. Education MD, University of Louvain, Brussels Specialization in Internal Medicine, University of Louvain, Brussels PhD, University of Louvain, Brussels Achievements Prix scientifique Perdieus-Petit